Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Sleep in Stimulant Use Disorder
NCT06444256Phase 2Recruiting
- Sponsor
- UTHealth Houston
- Start
- Jul 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in stimulant use disorder (SUD), sponsored by UTHealth Houston. Started Jul 2024; status: recruiting.
02
Drugs
suvorexant
03
Conditions
stimulant use disorder (SUD)
Beyond the preview
Go deeper on NCT06444256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06444256.